Skip to content
Odyssey Therapeutics
-
Evotec inks AI drug discovery deal with Odyssey Therapeutics for inflammatory diseases
The companies will combine Evotec’s screening technologies, compound libraries and AI-enabled discovery platform with Odyssey’s expertise in the biology of autoimmune and inflammatory diseases.